a. 12.0 g/dL (120 g/L)
b. 12.5 g/dL (125 g/L)
c. 13.0 g/dL (130 g/L)
d. 13.5 g/dL (135 g/L)
c. 13.0 g/dL (130 g/L)
a. a reactive test for Babesia species
b. residence in an endemic malaria region for 5 years
c. positive test for Trypanosoma cruzi (Chagas Disease)
d. history of chicken pox vaccination
c. positive test for Trypanosoma cruzi (Chagas Disease)
a. a 62-year old female with a blood pressure of 210/80
b. 18-year old female who weighs 100 lb
c. 40-year old male with a pulse of 115
d. 82-year old male with a hemoglobin of 13.5 g/dL
d. 82-year old male with a hemoglobin of 13.5 g/dL
a. a tattoo 5 months previously
b. recent close contact with a patient with viral hepatitis
c. 2 units of blood transfused 4 months previously
d. confirmed positive test for HBsAg 10 years previously
d. confirmed positive test for HBsAg 10 years previously
a. hepatitis B immune globulin 2 months ago
b. HIV prevention drugs 6 months ago
c. blood transfusion 2 months ago
d. travel to malaria endemic country 1 month ago
b. HIV prevention drugs 6 months ago
a. 150,000/uL
b. 200,000/uL
c. 250,000/uL
d. 300,000/uL
a. 150,000/uL
a. hypochlorite
b. green soap
c. 10% acetone
d. povidone iodine
d. povidone iodine
a. 8
b. 12
c. 16
d. 24
c. 16
a. Trypanosoma cruzi
b. Plasmodium falciparum
c. HCV
d. CMV
b. Plasmodium falciparum
a. use of 18 gauge needle
b. diversion pouch
c. green soap scrub
d. UV irradiation
b. diversion pouch
a. 11.0 g/dL
b. 12.0 g/dL
c. 12.5 g/dL
d. 13.0 g/dL
a. 11.0 g/dL
a. complete Rh phenotyping
b. anti-CMV testing
c. direct antiglobulin test
d. serological test for syphilis
d. serological test for syphilis
a. use of fresh frozen plasma from male donors
b. use of fresh frozen plasma from female donors
c. pathogen reduction treatment of fresh frozen plasma
d. leukocyte-reduced fresh frozen plasma
a. use of fresh frozen plasma from male donors
a. pathogen reduction technology failure
b. donor in the window period of early infection
c. leukocyte-reduction failure
d. donor history questionnaire not completed
b. donor in the window period of early infection
Anti-A: 0
Anti-B: 0
A1 cell: 4+
B cell: 4+
Anti-D: 0
Rh control: 0
Before labelling blood components from this donation, what additional testing must be completed?
a. test donor RBCs with Anti-A, B
b. test donor RBCs with Anti-H
c. perform weak D testing on donor RBCs
d. test donor serum with A1 cells
c. perform weak D testing on donor RBCs
a. set up another culture to confirm positivity
b. determine sensitivity to antibiotics
c. retrieve the unit if issued for transfusion
d. identify the organism
c. retrieve the unit if issued for transfusion
a. 1-6℃
b. 1-10℃
c. 18-20℃
d. 20-24℃
b. 1-10℃
a. 1-6℃
b. 1-10℃
c. 18-20℃
d. 20-24℃
d. 20-24℃
a. 6 hours
b. 12 hours
c. 5 days
d. 35 days
d. 35 days
a. cryoprecipitated AHF, 4℃
b. fresh frozen plasma (FFP), -20℃
c. red blood cells, frozen, -40℃
d. platelets, 37℃
b. fresh frozen plasma (FFP), -20℃
a. 6
b. 24
c. 48
d. 72
b. 24
a. discard the units as they were issued to a specific patient
b. inspect units and establish that appropriate temperature has been maintained
c. continue to store in cooler since surgery is rescheduled for tomorrow
d. put units back into inventory as only 40 minutes has elapsed since issue
b. inspect units and establish that appropriate temperature has been maintained
a. 1-6℃
b. 1-10℃
c. 10-18℃
d. 20-24℃
d. 20-24℃
a. platelets
b. fresh frozen plasma
c. red blood cells
d. cryoprecipitated AHF
c. red blood cells